Aandeel ISKJ HUMAN STEM CELLS INSTITUTE
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Human Stem Cells Institute

Aandelen

ISKJ

RU000A0JNAB6

slotkoers Moscow Micex - RTS
Andere beurzen
 00:00:00 08-07-2022 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
59,54 RUB +1,43% Intraday-grafiek van Human Stem Cells Institute -.--% -.--%
26/04 Artgen Biotech PJSC rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
2023 Artgen Biotech PJSC rapporteert resultaten voor het halfjaar dat eindigde op 30 juni 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023
Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2022
GENETICO PJSC has completed an IPO in the amount of RUB 178.8 million.
GENETICO PJSC has filed an IPO.
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Half Year Ended June 30, 2022
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received RUB 611.63608 million in funding from PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2021
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company acquired 6.93% stake in Public Joint-Stock Company "Human Stem Cells Institute".
GENETICO LLC announced that it expects to receive RUB 228.948921 million in funding from Public Joint-Stock Company "Human Stem Cells Institute"
Public Joint-Stock Company Human Stem Cells Institute Reports Earnings Results for the Half Year Ended June 30, 2021
Public Joint-Stock Company "Human Stem Cells Institute" announced that it expects to receive funding from PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received RUB 400 million in funding from Limited Liability Company "IceGen 2"
Public Joint-Stock Company Human Stem Cells Institute Reports Earnings Results for the Full Year Ended December 31, 2020
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received funding from Limited Liability Company "IceGen 2"
Public Joint-Stock Company "Human Stem Cells Institute" and Artur Isaev acquired 17.79% interest in GENETICO LLC from RVC Biopharmaceutical Investments, Limited liability Company, managed by RVC, Investment Arm.
Public Joint-Stock Company "Human Stem Cells Institute" announced that it expects to receive funding from Limited Liability Company "IceGen 2"
An unknown buyer acquired 15% stake in Human Stem Cells Institute PJSC from Mezhdunarodnogo Meditsinskogo Centra Obrabotki i Kriokhraneniya Biomaterialy.
Human Stem Cells Institute PAO Announces Dividend
Artur Isayev acquired 16.68% stake in Human Stem Cells Institute PJSC.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ISKJ
  4. Nieuws Human Stem Cells Institute
  5. Andere talen